中华皮肤科杂志 ›› 2015, Vol. 48 ›› Issue (12): 860-863.

• 论著 • 上一篇    下一篇

Kaposi肉瘤相关疱疹病毒8型相关微小RNA k12-1和k12-12在Kaposi肉瘤组织中的表达及意义

吴秀娟1,赵宗峰2,普雄明3   

  1. 1. 新疆维吾尔自治区人民医院皮肤性病科
    2. 新疆乌鲁木齐市天山区天池路91号维吾尔自治区人民医院临床医学研究中心
    3. 乌鲁木齐市新疆维吾尔自治区人民医院皮肤科
  • 收稿日期:2015-01-12 修回日期:2015-09-30 出版日期:2015-12-15 发布日期:2015-12-01
  • 通讯作者: 吴秀娟 E-mail:wxj7795@163.com
  • 基金资助:

    新疆经典型Kaposi肉瘤差异表达的miRNA筛选及其发病的民族差异性研究;miR-126-3p靶向VEGFA基因表达对卡波西肉瘤的影响及机制研究

Expressions of Kaposi′s sarcoma-associated herpesvirus type 8-associated microRNAs k12-1 and k12-12 in Kaposi′s sarcoma and their significance

  • Received:2015-01-12 Revised:2015-09-30 Online:2015-12-15 Published:2015-12-01
  • Contact: 吴秀娟 Wu Xiu-juan E-mail:wxj7795@163.com

摘要:

目的 检测Kaposi肉瘤肿瘤组织中Kaposi肉瘤相关疱疹病毒8型相关微小RNA k12-1(kshv-miR-k12-1)和k12-12(kshv-miR-k12-12)的表达,并探讨其与Kaposi肉瘤病理分期、HIV感染、人疱疹病毒8型(HHV-8)感染、皮损面积之间的关系。 方法 选取液氮保存的Kaposi肉瘤肿瘤组织和瘤旁正常组织18对,采用Trizol法提取标本组织中的总RNA并反转录成cDNA,采用SYBR Green实时荧光定量PCR法定量检测kshv-miR-k12-1和kshv-miR-k12-12,比较Kaposi肉瘤肿瘤组织及其瘤旁组织中kshv-miR-k12-1和kshv-miR-k12-12表达的差异,并分析其与Kaposi肉瘤病理分期、HIV和HHV-8感染、皮损面积之间的关系。结果 kshv-miR-k12-1和kshv-miR-k12-12在Kaposi肉瘤肿瘤组织中的2-?驻?驻Ct值分别为(1.016 ± 1.645)和(2.104 ± 1.973),明显高于瘤旁正常组织,分别为0.029 ± 0.019(t = 2.542,P = 0.016)和0.102 ± 0.093(t = 4.301, P = 0.000)。不同HIV和HHV-8感染状态、病理分期、皮损面积患者的kshv-miR-k12-1和kshv-miR-k12-12表达差异均无统计学意义(均P > 0.05)。 结论 kshv-miR-k12-1和kshv-miR-k12-12在Kaposi肉瘤肿瘤组织中呈明显高表达,但与HIV感染、HHV-8感染、病理分期及皮损面积无明显相关。

Abstract:

Wu Xiujuan*, Zhao Zongfeng, Pu Xiongming. *Department of Dermato-venereology, People′s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China Corresponding author: Pu Xiongming, Email: puxiongming@126.com 【Abstract】 Objective To measure the expressions of Kaposi′s sarcoma-associated herpesvirus type 8 associated-microRNAs k12-1 (kshv-miR-k12-1) and k12-12 (kshv-miR-k12-12) in Kaposi′s sarcoma tissue, and to assess their relationship with pathological stage and lesion area of Kaposi′s sarcoma, HIV infection, and human herpesvirus type 8 (HPV-8) infection. Methods Totally, 18 paired tissue specimens stored in liquid nitrogen from Kaposi′s sarcoma lesions and paralesional skin were collected. Total RNAs were extracted from these specimens by using Trizol reagent, and reversely transcribed into cDNA. SYBR Green real-time fluorescence-based quantitative PCR was performed to measure the expressions of kshv-miR-k12-1 and kshv-miR-k12-12 in these specimens. The relationship of kshv-miR-k12-1 and kshv-miR-k12-12 expressions with the pathological stage and lesion area of Kaposi′s sarcoma, HIV and HPV-8 infections was analyzed. Results Compared with paralesional normal skin, Kaposi′s sarcoma lesions showed significantly increased expressions of kshv-miR-k12-1 (2-ΔΔCt: 1.016 ± 1.645 vs. 0.029 ± 0.019, t = 2.542, P = 0.016) and kshv-miR-k12-12 (2-ΔΔCt: 2.104 ± 1.973 vs. 0.102 ± 0.093, t = 4.301, P = 0.000). There were no significant differences in the expressions of kshv-miR-k12-1 or kshv-miR-k12-12 between patients with HIV or HPV-8 infection and those without, among patients with different pathological stages of Kaposi′s sarcoma, or among patients with different lesion areas (all P > 0.05). Conclusion Both kshv-miR-k12-1 and kshv-miR-k12-12 are highly expressed in Kaposi′s sarcoma, but neither of their expressions is related to HIV or HPV-8 infection, pathological stage or lesion area of Kaposi′s sarcoma.